Peripheral Neuropathy Trial, Recruiting NCT07148388 Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT07148388
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with peripheral neuropathic pain (nerve pain originating outside the brain and spinal cord) according to standard international criteria
  • People whose pain started at least three months ago
  • People experiencing at least moderate pain levels, rated 3 or above on a standard pain scale
  • People aged 18 years or older
  • People whose pain medications or treatments have remained unchanged for at least two weeks before joining and are expected to stay the same throughout the trial
  • People who are willing to receive TMS (a non-invasive brain stimulation technique) and are able to complete the required assessments during the trial

Who may not be able to join:

  • People for whom TMS treatment is considered unsafe, such as those who have metal implants in their body or a history of seizures
  • People with severe depression or anxiety, as measured by standard clinical rating scales
  • People with significant communication difficulties (aphasia) or problems with memory and thinking, as measured by a standard cognitive screening tool
  • People with serious illness caused by cancer or other major conditions
  • People with severe heart or lung problems, or who are in a state of extreme physical weakness
  • People with a history of misuse of alcohol or drugs

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 86-15595512306

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
12 September 2025
Est. completion
1 September 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Visual analogue scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov